2021, Kortewille, Bianca, Springer, Armin, Strunk, Jennifer

Photocatalysts composed of vanadium oxide species supported on commercial MgO and ZrO2 are investigated in selective methanol oxidation. Both support oxides are insulators, so the vanadium oxide species are expected as sole active component in photocatalysis. However, the pure supports showed considerable activity: Bare MgO was more active than MgO-supported vanadia catalysts, and ZrO2 showed intermediate activity. By various characterization methods, the presence of TiO2 (anatase) in the MgO support, and the presence of Zn, possibly as ZnO, in ZrO2 is demonstrated. The present study highlights that photocatalysts containing commercial supports must be carefully checked for impurity-related photocatalytic performance. © 2021 The Authors

2023, Vanhoutte, Roeland, Barniol-Xicota, Marta, Chiu, Winston, Vangeel, Laura, Jochmans, Dirk, De Jonghe, Steven, Zidane, Hadeer, Barr, Haim M., London, Nir, Neyts, Johan, Verhelst, Steven H. L.

The COVID-19 pandemic has revealed the vulnerability of the modern, global society. With expected waves of future infections by SARS-CoV-2, treatment options for infected individuals will be crucial in order to decrease mortality and hospitalizations. The SARS-CoV-2 main protease is a validated drug target, for which the first inhibitor has been approved for use in patients. To facilitate future work on this drug target, we designed a solid-phase synthesis route towards azapeptide activity-based probes that are capped with a cysteine-reactive electrophile for covalent modification of the active site of Mpro. This design led to the most potent ABP for Mpro and one of the most potent inhibitors reported thus far. We demonstrate that this ABP can be used to visualize Mpro activity and target engagement by drugs in infected cells.